[O-34] Oral Session 34
Clinical trial and Regenerative medicine 2 E

[O-34-1] Development of antidote for therapeutic oligonucleotides which reduces the acute toxicity

^○Masahiro Ohara¹, Kazunori Takagi², Kie Yoshida¹, Yusuke Maeda², Rintaro Hara¹, Kazuki Sato², Tetsuya Nagata¹, Takeshi Wada², Takanori Yokota¹ (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan, 2.Graduate School of Pharmaceutical Sciences, Tokyo University of Science)